Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 27, 2000

View Archived Issues

Pamidronate improves osteoporosis following lung transplant in cystic fibrosis patients

Caprylocaproyl macrogolglycerides increase absorption of intranasal migraine treatment

Triazine derivative inhibits angiogenesis in vivo

MacroMed's OncoGel enters phase I

Cubist acquisition of TerraGen finalized

Drug discovery alliance formed by Synt:em and Morphochem

Unimed submits NDA for eprosartan/hydrochlorothiazide combination tablet

Biogen extends trial of interferon beta-1a in multiple sclerosis

Motor complications reduced by pramipexole treatment in early Parkinson's

Early vs. late treatment with antioxidant in hemorrhagic shock

Pharmacological and pharmacokinetic profile of potent Merck HIV protease inhibitor

Sitafloxacin proves useful in serious, difficult-to-treat systemic infections in humans

RSD-1019: a potential new approach to preventing ischemia-induced arrhythmias

Prophylactic vaccine for hospital pathogens presented at ASA 2000

Therion and Aventis expand cancer vaccine alliance

Hepatic metabolism of ciclesonide discussed at Xenobiotics meeting in Japan

New protein from leeches with utility in thromboembolic diseases

Alza's Caelyx approved in E.U. for advanced ovarian cancer

Novel dimeric neuraminidase inhibitors designed at Biota

ADIR presents series with 5-HT reuptake-blocking activity and their use

Recently issued patent covers new melatonin receptor ligands synthesized at ADIR

Wakamoto identifies novel antibiotics for Gram-positive infections

Antifibrotic agents patented by Sumitomo

Banyu claims new series of piperidine chemokine antagonists

RXR-selective retinoids synthesized at Allergan for use in skin and other disorders

Arena reaches milestone in CART collaboration with Taisho

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 8, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...